IMR Press / FBE / Volume 2 / Issue 3 / DOI: 10.2741/E168

Frontiers in Bioscience-Elite (FBE) is published by IMR Press from Volume 13 Issue 2 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Biomarkers in lung cancer
Show Less
1 Department of Medical Oncology, CRO-IRCCS, Aviano (PN), Italy
2 Department of Surgery, University of Catania, Italy
Front. Biosci. (Elite Ed) 2010, 2(3), 1099–1104;
Published: 1 June 2010

Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.

Back to top